Frequency Therapeutics' Series A Round

Frequency Therapeutics raised a round of funding on April 11, 2017.

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables …

Articles about Frequency Therapeutics' Series A Round: